GRO Biosciences on building therapies from non-standard amino acids — the building blocks outside biology’s usual set of 20 — to improve protein stability, delivery and drug durability.

One Health Company co-founder Christina Kelly Lopes on FidoCure, precision cancer treatment for dogs, and why naturally occurring canine cancer is a powerful window into the human disease.

Beacon Biosignals co-founder and CEO Jacob Donoghue on bringing precision medicine to neurology, using EEG and machine learning to pick the right therapy for the right brain.

A look at Google’s Med-PaLM 2 and what large language models mean for medicine, from search and software to the prospect of a chatbot as a first point of clinical contact.